• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗链球菌溶血素 O 滴度升高与未经治疗的 Takayasu 动脉炎患者的二尖瓣关闭不全密切相关。

Elevated antistreptolysin O titer is closely related to cardiac mitral insufficiency in untreated patients with Takayasu arteritis.

机构信息

Department of Rheumatology and Immunology, Beijing Anzhen Hospital, Capital Medical University, 2 Anzhen Road, Chaoyang District, Beijing, China.

Department of Cardiovascular surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.

出版信息

BMC Cardiovasc Disord. 2020 Feb 3;20(1):52. doi: 10.1186/s12872-020-01364-w.

DOI:10.1186/s12872-020-01364-w
PMID:32013899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6996160/
Abstract

BACKGROUND

The etiology of Takayasu arteritis (TA) is unknown; however, a possible relationship between streptococcal infection and TA has been proposed. This study aimed to identify the clinical features and cardiac valvular involvement in untreated TA patients with an elevated antistreptolysin O (ASO) titer.

METHODS

In this retrospective study, the clinical characteristics and features of valvular involvement were compared in TA patients with or without an elevated ASO titer.

RESULTS

Of the 74 untreated TA patients, 13 patients were found have elevated ASO titers (17.6%). Mitral insufficiency was the most common in patients with elevated ASO (69.2%, 9/13), followed by aortic valve insufficiency (46.2%, 5/13) and tricuspid insufficiency (46.2%, 5/13), which were no significantly different than that in normal ASO group. The proportions of moderate to severe mitral (30.8% vs 1.6%, p = 0.000) and tricuspid valve (15.4% vs 1.64%, p = 0.023) insufficiency in the ASO positive group were significantly higher than those in the ASO negative group. The odds of mitral regurgitation in patients with elevated ASO titers were 3.9 times higher than those in the group with normal ASO titers (p = 0.053, OR = 3.929, 95% confidence interval [CI]: 0.983-15.694). Furthermore, the risk of moderate to severe mitral insufficiency in patients with elevated ASO titers was 41.6 times higher than that in patients with normal ASO titers (p = 0.002, OR = 41.600, 95% CI: 3.867-447.559).

CONCLUSIONS

An increase in ASO titer is related to valvular involvement in TA and is closely linked to mitral insufficiency.

摘要

背景

Takayasu 动脉炎(TA)的病因尚不清楚;然而,已经提出链球菌感染与 TA 之间可能存在关系。本研究旨在确定未经治疗的抗链球菌溶血素 O(ASO)滴度升高的 TA 患者的临床特征和心脏瓣膜受累情况。

方法

在这项回顾性研究中,比较了 ASO 滴度升高和正常的 TA 患者的临床特征和瓣膜受累情况。

结果

在 74 例未经治疗的 TA 患者中,发现 13 例患者 ASO 滴度升高(17.6%)。ASO 滴度升高的患者中最常见的是二尖瓣关闭不全(69.2%,9/13),其次是主动脉瓣关闭不全(46.2%,5/13)和三尖瓣关闭不全(46.2%,5/13),与 ASO 正常组无显著差异。ASO 阳性组中中度至重度二尖瓣(30.8%比 1.6%,p=0.000)和三尖瓣(15.4%比 1.64%,p=0.023)关闭不全的比例明显高于 ASO 阴性组。ASO 滴度升高患者的二尖瓣反流发生率是 ASO 滴度正常患者的 3.9 倍(p=0.053,OR=3.929,95%置信区间[CI]:0.983-15.694)。此外,ASO 滴度升高患者中中度至重度二尖瓣关闭不全的风险是 ASO 滴度正常患者的 41.6 倍(p=0.002,OR=41.600,95%CI:3.867-447.559)。

结论

ASO 滴度升高与 TA 中的瓣膜受累有关,与二尖瓣关闭不全密切相关。

相似文献

1
Elevated antistreptolysin O titer is closely related to cardiac mitral insufficiency in untreated patients with Takayasu arteritis.抗链球菌溶血素 O 滴度升高与未经治疗的 Takayasu 动脉炎患者的二尖瓣关闭不全密切相关。
BMC Cardiovasc Disord. 2020 Feb 3;20(1):52. doi: 10.1186/s12872-020-01364-w.
2
Cardiac valvular involvement of Takayasu arteritis.大动脉炎的心脏瓣膜受累
Clin Rheumatol. 2021 Feb;40(2):653-660. doi: 10.1007/s10067-020-05290-2. Epub 2020 Jul 14.
3
Cardiac Valve Involvement in Takayasu Arteritis Is Common: A Retrospective Study of 1,069 Patients Over 25 Years.Takayasu 动脉炎中常见心脏瓣膜受累:25 年以上 1069 例患者的回顾性研究。
Am J Med Sci. 2018 Oct;356(4):357-364. doi: 10.1016/j.amjms.2018.06.021. Epub 2018 Jun 30.
4
[Cardiac manifestations of Takayasu's arteritis: apropos of 5 cases].[高安动脉炎的心脏表现:附5例报告]
Rev Med Interne. 1999 Jun;20(6):476-82. doi: 10.1016/s0248-8663(99)80082-4.
5
[Clinical data analysis of valvular involvement in Takayasu arteritis].[大动脉炎瓣膜受累的临床数据分析]
Zhonghua Yi Xue Za Zhi. 2016 Jul 19;96(27):2138-41. doi: 10.3760/cma.j.issn.0376-2491.2016.27.005.
6
[Antistreptolysin-o latex test. A simple screening method for the determination of antistreptolysin-o antibodies].[抗链球菌溶血素O乳胶试验。一种用于测定抗链球菌溶血素O抗体的简单筛查方法]
Z Rheumatol. 1975 Mar-Apr;34(3-4):76-86.
7
Clinical value of antistreptolysin O levels in adult patients with tonsillitis: report I.抗链球菌溶血素O水平在成年扁桃体炎患者中的临床价值:报告I。
Eur Arch Otorhinolaryngol. 2017 Apr;274(4):2035-2039. doi: 10.1007/s00405-016-4393-7. Epub 2016 Nov 15.
8
Echocardiographic versus histologic findings in Marfan syndrome.马凡综合征的超声心动图与组织学检查结果对比
Tex Heart Inst J. 2015 Feb 1;42(1):30-4. doi: 10.14503/THIJ-13-3848. eCollection 2015 Feb.
9
The heart of the matter: an atypical presentation of Takayasu arteritis in the Pediatric Emergency Department.
Pediatr Emerg Care. 2011 Sep;27(9):857-9. doi: 10.1097/PEC.0b013e31822c2836.
10
[Heart valvular and coronary manifestations of Takayasu disease. Apropos of a surgically-treated case].[大动脉炎的心脏瓣膜和冠状动脉表现。关于一例手术治疗病例]
Arch Mal Coeur Vaiss. 1992 Dec;85(12):1865-7.

引用本文的文献

1
Takayasu arteritis: a cohort of Italian patients and recent pathogenetic and therapeutic advances.Takayasu 动脉炎:意大利患者队列及近期发病机制和治疗进展。
Clin Exp Med. 2021 Feb;21(1):49-62. doi: 10.1007/s10238-020-00668-7. Epub 2020 Oct 7.

本文引用的文献

1
Valve Disease in Heart Failure: Secondary but Not Irrelevant.心力衰竭中的瓣膜病:次要但并非无关紧要。
Heart Fail Clin. 2019 Apr;15(2):219-227. doi: 10.1016/j.hfc.2018.12.014. Epub 2019 Feb 10.
2
Cardiac Valve Involvement in Takayasu Arteritis Is Common: A Retrospective Study of 1,069 Patients Over 25 Years.Takayasu 动脉炎中常见心脏瓣膜受累:25 年以上 1069 例患者的回顾性研究。
Am J Med Sci. 2018 Oct;356(4):357-364. doi: 10.1016/j.amjms.2018.06.021. Epub 2018 Jun 30.
3
New Insights on the Pathogenesis of Takayasu Arteritis: Revisiting the Microbial Theory.
大动脉炎发病机制的新见解:重新审视微生物理论。
Pathogens. 2018 Sep 6;7(3):73. doi: 10.3390/pathogens7030073.
4
Acute rheumatic fever.急性风湿热。
Lancet. 2018 Jul 14;392(10142):161-174. doi: 10.1016/S0140-6736(18)30999-1. Epub 2018 Jun 29.
5
mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G.mTOR 通路在 Takayasu 动脉炎患者的内皮细胞中被激活,并受血清免疫球蛋白 G 调节。
Rheumatology (Oxford). 2018 Jun 1;57(6):1011-1020. doi: 10.1093/rheumatology/key017.
6
Takayasu arteritis: challenges in diagnosis and management.Takayasu 动脉炎:诊断和治疗中的挑战。
Heart. 2018 Apr;104(7):558-565. doi: 10.1136/heartjnl-2016-310848. Epub 2017 Nov 25.
7
Clinical Characteristics of Heart Involvement in Chinese Patients with Takayasu Arteritis.中国 Takayasu 动脉炎患者心脏受累的临床特征。
J Rheumatol. 2017 Dec;44(12):1867-1874. doi: 10.3899/jrheum.161514. Epub 2017 Aug 15.
8
Epidemiology of Takayasu arteritis.大动脉炎的流行病学
Presse Med. 2017 Jul-Aug;46(7-8 Pt 2):e197-e203. doi: 10.1016/j.lpm.2017.05.034. Epub 2017 Jul 26.
9
Cause of death in Chinese Takayasu arteritis patients.中国大动脉炎患者的死因
Medicine (Baltimore). 2016 Jul;95(27):e4069. doi: 10.1097/MD.0000000000004069.
10
Association between rheumatic fever and Takayasu's arteritis - Case report.风湿热与高安动脉炎之间的关联——病例报告
Rev Bras Reumatol Engl Ed. 2016 Mar-Apr;56(2):178-80. doi: 10.1016/j.rbre.2014.09.003. Epub 2015 Feb 20.